Oxazole-based ferroptosis inhibitors with promising properties to treat central nervous system diseases
Source
Journal of medicinal chemistry - ISSN 0022-2623-68:4 (2025) p. 4908-4928
Exploring Fibroblast Activation Protein (FAP) in the tumor microenvironment and Crohn’s disease using novel FAP-selective tools and methods
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Pharmaceutical Sciences, 2025,xv, 347 p.
An interdisciplinary approach provides insights into the pronounced selectivity of Compound 42 for DPP9
Source
ChemMedChem - ISSN 1860-7179- (2024) p. 1-13
Computational study of DPP8 and DPP9 : fundamental insights and inhibitor design
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Pharmaceutical Sciences, 2024,242 p.
Cosolvent molecular dynamics applied to DPP4, DPP8 and DPP9 : reproduction of important binding features and use in inhibitor design
Source
Journal of Chemical Information and Modeling - ISSN 1549-9596-64:71 (2024) p. 7650-7665